Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127166) titled 'A Single-Center, Single-Arm Clinical Study of QL1706 Combined with Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Unresectable/Advanced Metastatic Esophageal Squamous Cell Carcinoma' on June 25.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Yancheng First People's Hospital
Condition:
Locally advanced unresectable or advanced metastatic esophageal squamous cell carcinoma
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-07-01
Target Sample Size: Experimental group:29;
Countries of Recruitment:
China
To know more, visit https://...